RXO to Be Acquired by C.H. Robinson for $30.25/Share in $5.8B Deal
RXO has more than doubled off its 52-week low of $10.425 on elevated volume (2.0× avg).
Summary
RXO agreed to be acquired by C.H. Robinson for $30.25 per share in a $5.8 billion stock-and-cash transaction, with closing expected in the first half of 2027.
Updates
· SEC 425 — The 425 filing details merger consideration: $17.25 cash plus 0.0856 CHRW shares, or $30.25 cash, or 0.1992 CHRW shares per RXO share, subject to proration; MFN Partners holds 17.04% and agreed to vote in favor.
Key Events · M&A and Partnerships · RXO
-
Definitive Merger Agreement Signed
RXO entered into a definitive agreement to be acquired by C.H. Robinson Worldwide for $17.25 cash plus 0.0856 CHRW shares per RXO share, implying $30.25 per share total consideration and a $5.8 billion transaction value.
-
Election Mechanics and Proration
Stockholders may elect all-cash ($30.25), all-stock (0.1992 CHRW shares), or standard mixed consideration, subject to proration designed to maintain approximately 57% cash / 43% stock aggregate mix.
-
Largest Stockholder Commits Support
MFN Partners, LP signed a voting and support agreement covering 28,109,942 shares (~17.04% of outstanding), agreeing to vote in favor of the transaction and not transfer its shares.
-
$4.5B Bridge Financing Secured
C.H. Robinson obtained a fully underwritten $4.5 billion 364-day senior unsecured bridge facility from Morgan Stanley Senior Funding to finance the cash consideration and refinance RXO's existing credit facility.
Analysis · RXO · Energy & Transportation
RXO has entered into a definitive merger agreement to be acquired by C.H. Robinson Worldwide in a stock-and-cash transaction valued at approximately $5.8 billion. RXO stockholders will receive $17.25 in cash plus 0.0856 shares of C.H. Robinson common stock per RXO share, with election options for all-cash ($30.25) or all-stock (0.1992 shares) consideration subject to proration. The deal represents a 27% premium to RXO's 90-day VWAP and is expected to close in the first half of 2027, pending RXO stockholder approval and regulatory clearances. MFN Partners, LP — RXO's largest stockholder with approximately 17% of outstanding shares — has signed a voting and support agreement committing to vote in favor of the transaction. C.H. Robinson has secured a $4.5 billion bridge facility from Morgan Stanley to fund the cash portion and expects approximately $300 million in net run-rate cost synergies within two years post-close.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 42.7% of the 288 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RXO was trading at $28.72 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $3.9B. The 52-week trading range was $10.43 to $29.90. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.